Literature DB >> 11133877

Adrenergic receptor activated ion transport in human fetal retinal pigment epithelium.

R H Quinn1, J N Quong, S S Miller.   

Abstract

PURPOSE: To identify the apical and basolateral membrane mechanisms and intracellular signaling pathways in human fetal retinal pigment epithelium (HRPE) that mediate membrane voltage and resistance changes caused by apical membrane adrenergic receptor activation.
METHODS: Intact sheets of RPE-choroid from human fetal eyes were mounted in a modified Ussing chamber. Ringer's solution composition changes on the retina-facing and choroid-facing sides of the tissue were separately controlled. Intracellular microelectrodes recorded the membrane voltage and resistance changes after the addition of pharmacologic agents to the apical or basal baths.
RESULTS: Apical adrenergic agonists, isoproterenol and epinephrine (10(-8) M), depolarized the basolateral membrane, decreased total tissue resistance (R:(t)) and increased the ratio of apical-to-basolateral membrane resistance (R:(A)/R:(B)). Experiments using antagonists for alpha(1) and ss adrenergic receptors, prazosin and propranolol, respectively, indicated that both receptor types were present. The epinephrine responses were inhibited by apical bumetanide and basal 4,4'-diisothiocyanostilbene-2,2' disulfonic acid (DIDS). A cocktail of cyclic adenosine monophosphate (cAMP)-elevating agents produced basolateral membrane voltage and resistance changes very similar to the isoproterenol responses. The cAMP-induced electrical responses were strongly inhibited by basal 5-nitro-2-(3-phenylpropylamino)-benzoate (NPPB). Ionomycin (to elevate intercellular Ca(2+), [Ca(2+)](i)) produced electrical responses similar to those caused by epinephrine. The Ca(2+) responses were unaffected by NPPB but were inhibited by 3 mM DIDS in the basal bath.
CONCLUSIONS: The results provide evidence for two apical membrane adrenergic receptors, alpha(1) and ss, activated by epinephrine and isoproterenol, respectively. The membrane voltage and resistance changes produced by these two agonists mimic those produced by elevating [Ca(2+)](i) and [cAMP](i), suggesting that these ubiquitous signaling molecules activate separate basolateral membrane Cl channels inhibited by DIDS and NPPB, respectively. These two receptors, the apical membrane NaK2Cl cotransporters and the basolateral membrane Cl channels form a complex of proteins that help mediate fluid absorption across human RPE.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11133877

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  25 in total

1.  Functional abnormalities in the retinal pigment epithelium of CFTR mutant mice.

Authors:  Jiang Wu; Alan D Marmorstein; Neal S Peachey
Journal:  Exp Eye Res       Date:  2006-04-14       Impact factor: 3.467

2.  In vivo studies on the effects of alpha1-adrenoceptor antagonists on pupil diameter and urethral tone in rabbits.

Authors:  Martin C Michel; Hiroko Okutsu; Yukiko Noguchi; Masanori Suzuki; Akiyoshi Ohtake; Hironori Yuyama; Hiroko Yanai-Inamura; Masashi Ukai; Mai Watanabe; Akiyoshi Someya; Masao Sasamata
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2006-02-18       Impact factor: 3.000

3.  Confluent monolayers of cultured human fetal retinal pigment epithelium exhibit morphology and physiology of native tissue.

Authors:  Arvydas Maminishkis; Shan Chen; Stephen Jalickee; Tina Banzon; Guangpu Shi; Fei E Wang; Todd Ehalt; Jeffrey A Hammer; Sheldon S Miller
Journal:  Invest Ophthalmol Vis Sci       Date:  2006-08       Impact factor: 4.799

4.  Glutamate acts at NMDA receptors on fresh bovine and on cultured human retinal pigment epithelial cells to trigger release of ATP.

Authors:  David Reigada; Wennan Lu; Claire H Mitchell
Journal:  J Physiol       Date:  2006-06-29       Impact factor: 5.182

5.  Light-evoked responses of the retinal pigment epithelium: changes accompanying photoreceptor loss in the mouse.

Authors:  Ivy S Samuels; Gwen M Sturgill; Gregory H Grossman; Mary E Rayborn; Joe G Hollyfield; Neal S Peachey
Journal:  J Neurophysiol       Date:  2010-05-19       Impact factor: 2.714

6.  Retinal pigment epithelial function: a role for CFTR?

Authors:  Sasha Blaug; Richard Quinn; Judy Quong; Stephen Jalickee; Sheldon S Miller
Journal:  Doc Ophthalmol       Date:  2003-01       Impact factor: 2.379

Review 7.  Nanofiber Scaffold-Based Tissue-Engineered Retinal Pigment Epithelium to Treat Degenerative Eye Diseases.

Authors:  Nathan A Hotaling; Vladimir Khristov; Qin Wan; Ruchi Sharma; Balendu Shekhar Jha; Mostafa Lotfi; Arvydas Maminishkis; Carl G Simon; Kapil Bharti
Journal:  J Ocul Pharmacol Ther       Date:  2016-04-25       Impact factor: 2.671

8.  The effect of brimonidine on transepithelial resistance in a human retinal pigment epithelial cell line.

Authors:  Jung Hyun Park; Sung Joon Kim; Hyeong Gon Yu
Journal:  Korean J Ophthalmol       Date:  2010-06-05

9.  Attainment of polarity promotes growth factor secretion by retinal pigment epithelial cells: relevance to age-related macular degeneration.

Authors:  Shozo Sonoda; Parameswaran G Sreekumar; Satoru Kase; Christine Spee; Stephen J Ryan; Ram Kannan; David R Hinton
Journal:  Aging (Albany NY)       Date:  2009-12-27       Impact factor: 5.682

Review 10.  Functional roles of bestrophins in ocular epithelia.

Authors:  Alan D Marmorstein; Harold E Cross; Neal S Peachey
Journal:  Prog Retin Eye Res       Date:  2009-05-04       Impact factor: 21.198

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.